7:45-8:30
Registration and Coffee Networking
8:30 - 8:35
Welcome Remark
Perry Niro, President, Pharmed Canada
9:00 - 9:30
Global life sciences sector outlook
2016 Deals, M&A and partnering forecast for 2017
-
Douglas Loe, Analyst, Healthcare & Biotech, Echelon Wealth Partners
9:30-10:15
Partnering across the borders with Pharma Ventures
Moderated by Anie Perrault, Executive Director, BIOQuébec
-
Jennifer Hamilton, Senior Director, New Ventures (Canada), Johnson & Johnson Innovation
-
Steven Xanthoudakis, Director, Business Development & Licensing at Merck
-
Amyn Sayani, Ph.D., Director, R&D Alliances, GlaxoSmithKline Canada
Networking Break
Program 2016 ( Agende 2017 available soon)
Networking Break
14:30 - 15:30
How to commecialize Digital Health and Medical Technologies
Moderated by Jean-Francois Pariseau, Partner, Healthcare Fund, BDC Venture Capital
-
Ajit Singh, Partner, Artiman Ventures , Palo Alto
-
Daniel Hétu, Managing Director, Lumira Capital, Montréal
-
Kelly Holman, co-founder, Genesys Capital, Toronto
Luncheon Conference - Megatrends: Health Re-Imagined
-
Gautam Jaggi, Director, EY USA
10:15 - 10:35
16:45- 17:00 NEW
Biomed Propulsion, a new commercialization program of $ 100 million in life sciences
-
Vanessa Claveau, Chef d'équipe, Direction des sciences de la vie, Ministère de l’Économie, de la Science et de l’Innovation
-
Pierre Tessier, Directeur principal du financement spécialisé, Investissement Québec
10:35 - 11:30
Cross-border VC Deals: Joining the dots
Moderated by Stephen Nagler, Executive Director, MedPro Investors, New York
-
Alex Zisson, Managing Director, HIG Capital, New York
-
Caroline Stout, Investor, EcoR1 Capital, San Francisco
-
Elizabeth Douville, General Partner, GeneChem
15:30 15:45
15:45 - 16:45
Healthcare: Opportunities & Challenges for Medtech
-
Yvan Beaudoin, Executive Director, CTS Santé Fund
-
Steeve Asselin, Industrial Technology Advisor, (MedTech), National Research Council
-
Stéphane Pillette, Vice-President, Healthcare & Life Sciences, Anges Quebec
-
Arndt Welsch-Lehmann, Managing Partner, FOS Capital Partners, LLC, New York
17:00
Closing Remarks & Networking Cocktail
13:30 - 14:00 :
Startup Pitches
New this year, three companies will be invited to make a 5 minute pitch to our audience.
-
Francois Michaud, CEO, Feldan Therapeutics
-
Frédéric Leduc, Ph. D. , CEO, Immune Biosolutions
-
Maxime Ranger, CEO, Mperia Therapeutics Inc
14:00 - 14h30
Life Sciences EY Report 2016
Beyond borders, Reaching new heights
-
Lara Iob, CPA, Partner, EY Canada
-
Yann Lavallee, Partner, EY Canada
11:30 - 12:15
CEO Panel : Show me the money, dealing with VC's !
Moderated by Didier Leconte, Senior Director, Investments - Life Sciences, FSFTQ
-
David Young, M.D, KisoJi Biotechnology, Montréal
-
Philippe Douville , Founder and Chief Executive Officer, Milestone Pharmaceuticals Inc.
-
Michael Midmer, CEO, Zucara Therapeutics, Toronto
-
Lloyd Segal, EIR, Versant Ventures
8:35 - 9:00
Opening Conference
Normand Chouinard, First Vice-President, Investments, Fonds de solidarité FTQ